| Product Name | MF | CAS | Details |
|---|
| C11H10BrFO | Details |
| Paliperidone Impurity 25 | C5H6N2O | Details |
| Fasudil iMpurity 6 | Details |
| Fasudil Impurity 19 | Details |
| Sofosbuvir IMpurity 55 | Details |
| Risperidone EP Impurity L | C11H15ClN2O | 63234-80-0 | Details |
| Safinamide Impurity 1 | C17H20N2O2 | 133865-32-4 | Details |
| C28H36N4O5S-2 | Details |
| Pazufloxacin Impurity 5 | C15H15FN2O2 | 777824-29-0 | Details |
| Nifekalant Impurity 13 | Details |
| Nifekalant Impurity 18 | Details |
| Cabozantinib impurity M | Details |
| Levocarnitine EP Impurity A | C7H13ClNO2 | 6538-82-5 | Details |
| Fasudil Impurity 17 | C9H7Cl2NO2S | Details |
| Fasudil Impurity 13 | C9H6ClNO2S | Details |
| Nifekalant Impurity 5 | Details |
| Nifekalant Impurity 10 | Details |
| Levosimendan Impurity 11 | Details |
| Cabozantinib impurity O | Details |
| Safinamide Impurity 7 | C17H19FN2O2 | 174756-44-6 | Details |
| Mirabegron Impurity 11 | C21H24N4OS | 1581284-82-3 | Details |
| Fasudil iMpurity 5 | Details |
| Cabozantinib Impurity C | Details |
| Cabozantinib impurity H | Details |
| Sofosbuvir IMpurity 53 | C20H25FN3O9P | Details |
| Nintedanib Impurity 48 | C16H17N5O5 | 1798026-96-6 | Details |
| Olprinone | C14H10N4O | 106730-54-5 | Details |
| Nifekalant Impurity 2 | Details |
| Nifekalant Impurity 7 | Details |
| N-Nitroso Furosemide | C14H14N6O2 | 2244238-17-2 | Details |
| Cabozantinib impurity R | Details |
| Safinamide Impurity 3 | C17H19FN2O2 | 133865-88-0 | Details |
| Pentoxifylline EP Impurity J | C26H34N8O5 | 874747-30-5 | Details |
| Diacetylene EP Impurity D | C17H10O7 | 875535-35-6 | Details |
| Cabozantinib Impurity E | Details |
| Silodosin Impurity 4 | C25H32F3N3O4 | 2182279-45-2 | Details |
| Paliperidone Impurity 23 | Details |
| Nifekalant Impurity 14 | Details |
| Nifekalant Impurity 19 | Details |
| Cabozantinib impurity L | Details |
| Crisaborole | C14H10BNO3 | 906673-24-3 | Details |
| 4-Acetoxyisophthalic Acid | C10H8O6 | 5985-26-2 | Details |
| Fasudil Impurity 14 | Details |
| Safinamide Impurity 5 | C17H19FN2O2 | 861398-52-9 | Details |
| Nifekalant Impurity 11 | C13H15N3O4S | Details |
| Nifekalant Impurity 16 | Details |
| Cabozantinib impurity N | Details |
| Folic acid | C19H19N7O6 | 59-30-3 | Details |
| C11H10BrFO | Details |
| Details |
| Fasudil Impurity 11 | Details |
| Cefpodoxime Proxetil Impurity 9 | C25H33N5O11S2 | 1192365-87-9 | Details |
| Nifekalant Impurity 3 | Details |
| Nifekalant Impurity 8 | Details |
| LevosiMendan iMpurity 9 | Details |
| Cabozantinib impurity J | Details |
| WHDS Impurity 1 | C8H12N2O2S | 81760-42-1 | Details |
| Ethambutol EP Impurity C | C10H25ClN2O2 | 134566-79-3 | Details |
| Ibandronate sodium impurity 15 | C9H18N2 | 919491-64-8 | Details |
| Fasudil iMpurity 1 | C14H17N3O2S | Details |
| Details |
| Details |
| Fasudil Impurity 10 | C14H17N3O2S | Details |
| Cabozantinib Impurity F | Details |
| Sitagliptin Impurity 62 | C16H14F6N4O2 | 1253056-01-7 | Details |
| Sofosbuvir IMpurity 51 | Details |
| C9H7NO3S | Details |
| Paliperidone Impurity 24 | Details |
| Nifekalant Impurity 15 | Details |
| Nifekalant Impurity 20 | Details |
| Cabozantinib impurity Q | Details |
| Trifluridine | C10H11F3N2O5 | 70-00-8 | Details |
| Safinamide Impurity 8 | C17H19FN2O2 | 133865-89-1 | Details |
| Fasudil Impurity 18 | Details |
| Sofosbuvir IMpurity 54 | C12H17ClNO4P | Details |
| Safinamide Impurity 2 | C17H19FN2O2 | 202825-43-2 | Details |
| Nifekalant Impurity 12 | Details |
| Nifekalant Impurity 17 | Details |
| Cabozantinib impurity P | Details |
| Urapidil | C20H29N5O3 | 34661-75-1 | Details |
| Details |
| Fasudil Impurity 12 | C9H6ClNO2S | Details |
| Fasudil Impurity 15 | C9H7NO3S | Details |
| Lurasidone impurity 30 | C18H16N4S2 | Details |
| Nifekalant Impurity 4 | Details |
| Nifekalant Impurity 9 | Details |
| LevosiMendan iMpurity 10 | C11H12N2O2 | Details |
| Cabozantinib impurity I | Details |
| Litakast | C29H24Cl2N2O7S | 1025967-78-5 | Details |
| Safinamide Impurity 6 | C14H13FO2 | 690969-16-5 | Details |
| Fasudil iMpurity 4 | Details |
| Cabozantinib Impurity B | Details |
| Cabozantinib impurity G | Details |
| Sofosbuvir IMpurity 52 | Details |
| C21H16F4N4O3 | Details |
| Nifekalant Impurity 1 | Details |
| Nifekalant Impurity 6 | Details |
| LevosiMendan iMpurity 7 | Details |
| WHDS Impurity 2 | Details |
| Cabozantinib impurity K | Details |
| Product Total： Product Page： | ||||
| 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 | ||||